Loading...

JANX JANUX THERAPEUTICS INC Management Changes 8-K Filing

JNX

JNX

JANUX THERAPEUTICS INC

(JANX)

2025 8-K

Financial Results Report

Management Change

Financial Statements

Financial Statements

Financial Results

Public Offering

Clinical Data Update

Financial Results

Financial Results Announcement

Departure of Directors and ...

Financial Results Announcement

Financial Results Announcement

Public Offering

Suspension of Prospectus Su...

Capital Resources and Inter...

Earnings Reports

Financial Results Announcement

Equity Offerings

Results of Operations and F...

Resignation of CMO

Delisting Notice

Equity Offering

Financial Results Announcement

Departure of Directors

Financial Results Announcement

External Links:

On September 18, 2025, Byron Robinson, Ph.D., left his position as Chief Strategy Officer at Janux Therapeutics, Inc. without cause, per company policy.

AI Assistant

JANUX THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.